GIPRs have been localized to human pancreatic -cells, and intravenous GIP infusion activates GIPR and intracellular signaling in pancreatic -cells, augmenting glucagonotropic effects in hypoglycemic conditions in humans (130)
This trial focuses on obesity in adults with type 2 diabetes, addressing the critical question of how retatrutide performs when glycemic control is a co-primary endpoint alongside weight loss
As these innovative drugs progress through clinical trials, they stand at the forefront of new-generation treatments for aiding individuals seeking help to lose weight effectively
Semaglutides, tirzepatides and liraglutides are among the top GLP-1 medications for weight management
New England Journal of Medicine, 393 (11), 10651076
The efficacy of GLP-1RAs in AUD likely stems from their modulation of the brains reward circuitry, as evidenced by preclinical and clinical data [41, 42]